Y-Biologics, Inc. (KOSDAQ:338840)

Y-Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	207,046	113,678	230,299	-	-	-
Market Cap Growth	-4.58%	-50.64%	-	-	-	-
Enterprise Value	198,090	102,035	230,749	-	-	-
Last Close Price	13850.00	7690.00	15600.00	-	-	-
PS Ratio	34.74	19.73	66.19	-	-	-
PB Ratio	12.67	5.79	8.86	-	-	-
P/TBV Ratio	12.98	6.27	9.94	-	-	-
EV/Sales Ratio	33.24	17.71	66.33	-	-	-
Debt / Equity Ratio	0.04	0.04	0.11	0.25	0.21	0.16
Asset Turnover	0.28	0.22	0.12	0.12	0.11	0.16
Quick Ratio	6.42	10.58	7.39	1.60	2.91	3.35
Current Ratio	6.52	10.73	7.48	1.70	3.20	3.78
Return on Equity (ROE)	-32.72%	-28.23%	-90.84%	-77.73%	-54.50%	-40.90%
Return on Assets (ROA)	-18.41%	-20.30%	-21.27%	-34.84%	-24.67%	-11.53%
Return on Capital (ROIC)	-20.02%	-21.41%	-23.57%	-39.71%	-29.35%	-16.78%
Earnings Yield	-2.99%	-5.67%	-9.06%	-	-	-
FCF Yield	-1.52%	-6.16%	-3.39%	-	-	-
Buyback Yield / Dilution	-7.36%	-19.30%	-1.87%	-1.01%	-21.93%	-5.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.